one of the few high institutional own names in the bio space that i like. This one is going to moon on the platform and Duchenne ph1/2 data in late 2024/2025. This AAV capsid platform WORKS!! Company teamed up with Avanti to bring the platform to Friedreichs Ataxia too. They didnt want anything from them other than adopting the trial.... this will bring huge benefit to DMD and FA patients.
Market Data 
Markets 
AI
